Long-term storage of DNA-free RNA for use in vaccine studies

BioTechniques

Volumn 43, Issue 5, 2007, Pages 675-681

  Jones, Kathryn L ^a,b   Drane, Debbie ^c   Gowans, Eric J ^a,b  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c CSL LIMITED   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DELIVERY; PROTEINS; RNA; VACCINES; VIRUSES;

DISTILLED WATER; HEPATITIS C VIRUS (HCV) PROTEINS; TURBO DNASE; VACCINE DELIVERY VEHICLES;

DNA;

DEOXYRIBONUCLEASE; DNA; NITROGEN; RNA VACCINE; TREHALOSE; VIRUS PROTEIN;

ARTICLE; FREEZE DRYING; GENETIC TRANSFECTION; HEPATITIS C VIRUS; IMMUNOFLUORESCENCE; PROTEIN EXPRESSION; REPLICON; RNA ANALYSIS; RNA STABILITY; RNA TRANSCRIPTION; STORAGE; VACCINATION;

CELL LINE; CRYOPRESERVATION; DEOXYRIBONUCLEASES; DNA, VIRAL; HEPACIVIRUS; HUMANS; REPLICON; RNA, VIRAL; SPECIMEN HANDLING; TIME FACTORS; VACCINES; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 36448956746     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/000112593     Document Type: Article

References (31)

1. Mandl, C.W., J.H. Aberle, S.W. Aberl, H. Holzman, S.L. Allison, and F.X. Heinz. 1998. In vitro synthesized infectious RNA as an attenuated live vaccine in a flavivirus model. Nat. Med. 4:1438-1440.
2. Kofler, R.M., J.H. Aberle, S.W. Aberle, S.L. Allison, F.X. Heinz, and C.W. Mandl. 2004. Mimicking live flavivirus immunization with a non-infectious RNA vaccine. Proc. Natl. Acad. Sci. USA 101:1951-1956.
3. Pijlman, G.P., A. Suhrbier, and A. Khromykh. 2006. Kunjin virus replicons: and RNA based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications. Expert Opin. Biol. Ther. 6:135-145.
4. Aberle, J.H., S.W. Aberle, R.M. Kofler, and C.W. Mandl. 2005. Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus. J. Virol. 79:15107-15113.
5. Restifo, N.P., H. Ying, L. Hwang, and W.W. Leitner. 2000. The promise of nucleic acid vaccines. Gene Ther. 7:89-92.
6. Clark, K.R. and P.R. Johnson. 2001. Gene delivery of vaccines for infectious disease. Curr. Opin. Mol. Ther. 3:375-384.
7. Howarth, M. and T. Elliott. 2004. The processing of antigens delivered as DNA vaccines. Immunol. Rev. 199:27-39.
8. Carralot, J.P., J. Probst, I. Hoerr, B. Scheel, R. Teufel, G. Jung, H.G. Rammensee, and S. Pascolo. 2004. Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines. Cell. Mol. Life Sci. 61:2418-2424.
9. Hoerr, I., R. Obst, H.G. Rammensee, and G. Jung. 2000. In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. Eur. J. Immunol. 30:1-7.
10. Vignuzzi, M., S. Gerbaud, S. van der Werf, and N. Escriou. 2001. Naked RNA immunization with replicons derived from poliovirus and Samliki Forest virus genomes for the generation of a cytotoxic T cell response against the influenza virus nucleoprotein. J. Gen. Virol. 82:1737-1747.
11. Kieny, M.P., J. Blancou, R. Lathe, P.P. Pastoret, J.P. Soulebot, P. Desmettre, and J.P. Lecocq. 1988. Development of animal recombinant DNA vaccine and its efficacy in foxes. Rev. Infect. Dis. 10(Suppl4):S799- S802.
12. O'Hagan, D.T., M. Singh, and J.B. Ulmer. 2004. Microparticles for the delivery of DNA vaccines. Immunol. Rev. 199:191-200.
13. Estcourt, M.J., A.J. McMichael, and T. Hanke. 2004. DNA vaccines against human immunodeficiency virus. Immunol. Rev. 199:144-155.
14. Pascolo, S. 2004. Messenger RNA-based vaccines. Expert Opin. Biol. Ther. 4:1285-1294.
15. Khromykh, A.A. 2000. Replicon-based vectors of positive strand RNA viruses. Curr. Opin. Mol. Ther. 2:555-569.
16. Ward, S.M., R.W. Tindle, A.A. Khromykh, and E.J. Gowans. 2003. Generation of CTL responses using Kunjin replicon RNA. Immunol. Cell Biol. 81:73-78.
17. Anraku, I., T.J. Harvey, R. Linedale, J. Gardner, D. Harrich, A. Suhrbier, and A.A. Khromykh. 2002. Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity. J. Virol. 76:3791-3799.
18. Harvey, T.J., I. Anraku, R. Linedale, D. Harrich, J. Mackenzie, A. Suhrbier, and A.A. Khromykh. 2003. Kunjin virus replicon vectors for human immunodeficiency virus vaccine development. J. Virol. 77:7796-7803.
19. Hoerr, I., R. Obst, H.-G. Rammensee, and G. Jung. 2000. In vivo application of RNA leads to induction of specific cytotoxic T-lymphocytes and antibodies. Eur. J. Immunol. 30:1-7.
20. Teufel, R., J.P. Carralot, B. Scheel, J. Probst, S. Walter, G. Jung, I. Hoerr, H.-G. Rammensee, and S. Pascolo. 2005. Human peripheral blood mononuclear cells transfected with messenger RNA stimulate antigen-specific cytotoxic T-lymphocytes in vitro. Cell. Mol. Life Sci. 62:1755-1762.
21. Crowe, J.H., F.A. Hoekstra, and L.M. Crowe. 1992. Anhydrobiosis. Annu. Rev. Physiol. 54:579-599.
22. Eroglu, A., M.J. Russo, R. Bieganski, A. Fowler, S. Cheley, H. Bayley, and M. Toner. 2000. Intracellular trehalose improves the survival of cryopreserved mammalian cells. Nat. Biotechnol. 18:163-167.
23. Carninci, P., Y. Nisjiyama, A. Westove, M. Itoh, S. Nagaoka, N. Sasaki, Y. Okazaki, M. Muramatsu, and Y. Hayashizaki. 1998. Thermostabilization and thermoactivation of thermolabile enzymes by trehalose and its application for the synthesis of full length cDNA. Proc. Natl. Acad. Sci. USA 95:520-524.
24. Varnavski, A.N. and A.A. Khromykh. 1999. Noncytopathic Flavivirus replicon RNA-based system for expression and delivery of heterologous genes. Virology 255:366-375.
25. Scheel, B., S. Aulwurm, J. Probst, L. Stitz, I. Hoerr, H.G. Rammensee, M. Weller, and S. Pascolo. 2006. Therapeutic anti-tumour immunity triggered by injections of immunostimulating single-stranded RNA. Eur. J. Immunol. 36:2807-2816.
26. Gowans, E.J., K.L. Jones, M. Bharadwaj, and D.C. Jackson. 2004. Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus. J. Clin. Virol. 30:283-290.
27. Kyte, J.A., G. Kvalheim, S. Aamdal, S. Saeboe-Larsson, and G. Gaudernack. 2005. Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination. Cancer Gene Ther. 12:579-591.
28. Mu, L.J., G. Gaudernack, S. Saeboe-Larsson, H. Hammerstad, A. Tierens, and G. Kvalheim. 2003. A protocol for generation of clinical grade mRNA-transfected monocyte-derived dendritic cells for cancer vaccines. Scand. J. Immunol. 58:578-586.
29. Kalady, M.F., M.W. Onaitis, K.M. Padilla, S. Emani, D.S. Tyler, and S.K. Pruitt. 2002. Enhanced dendritic cell antigen presentation in RNA-based immunotherapy. J. Surg. Res. 105:17-24.
30. Vassilev, V.B., L.H. Gil, and R.O. Donis. 2001. Microparticle-mediated RNA immunization against bovine viral diarrhea virus. Vaccine 19:2012-2019.
31. Chang, G.-J., G. Kuno, D.E. Purdy, and B.S. Davis. 2004. Recent advancement in Flavivirus vaccine development. Expert Rev. Vaccines 3:199-220.